UroToday

The Optimal Treatment for Gleason Score 9-10 Prostate Cancer

Daniel Spratt and Alicia Morgans discuss clinical outcomes of patients with Gleason score 9-10 prostate cancer after definitive treatment. Long-term Survival in Men with Gleason Score 9-10 Treated ...
UroToday

SUO 2025: Preoperative ctDNA Predicts Upstaging and Recurrence in High-Risk NMIBC Undergoing Radical Cystectomy

(UroToday.com) The 2025 SUO annual meeting featured a urothelial carcinoma session and a presentation by Dr. Reuben Ben-David discussing preoperative ctDNA predicting upstaging and recurrence in ...
UroToday

Surgical Management of Kidney and Ureteral Stones: AUA Guideline (2026) Part II: Evaluation and Treatment of Patients with Kidney and/or Ureteral Stones.

This Guideline covers the surgical management of patients with ureteral and/or kidney stones and is intended for clinicians evaluating and managing patients with this disease. The summary presented ...
UroToday

Long-Term Follow-Up of Neoadjuvant Enzalutamide Plus Androgen Deprivation Therapy in Localized Prostate Cancer: A Secondary Analysis of a Neoadjuvant Feasibility Trial.

Neoadjuvant intense androgen deprivation therapy (ADT) with androgen receptor signaling inhibitors (ARSIs) has shown pathologic complete responses (pCR) in prostate cancer (PCa), but long-term ...
UroToday

AUA 2022: Is Capsular Abutment on MRI a Predictor of Extraprostatic Extension (EPE) on Radical Prostatectomy?

(UroToday.com) The 2022 American Urological Association Annual Meeting included a prostate cancer session featuring work from Dr. Mohammad Siddiqui and colleagues presenting results of their study ...